Fragile x syndrome

Behavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders

Volumn , Issue , 2014, Pages 146-163

  Pietropaolo, Susanna ^a   Subashi, Enejda ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84953317172     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/CBO9781107360556     Document Type: Chapter

References (174)

1. Arocena, D. G., Iwahashi, C. K., Won, N., et al. (2005) Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet 14: 3661-3671.
2. Ashley, C. T., Jr., Wilkinson, K. D., Reines, D., andWarren, S. T. (1993) FMR1 protein: Conserved RNP family domains and selective RNA binding. Science 262: 563-566.
3. Bailey, D. B., Jr., Hatton, D. D., Skinner, M., and Mesibov, G. (2001) Autistic behavior, FMR1 protein, and developmental trajectories in young males with Fragile X syndrome. J AutismDevDisord 31: 165-174.
4. Bailey, D. B., Jr., Mesibov, G. B., Hatton, D. D., et al. (1998) Autistic behavior in young boys with Fragile X syndrome. J Autism Dev Disord 28: 499-508.
5. Baker, K. B., Wray, S. P., Ritter, R., et al. (2010) Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments. Genes Brain Behav 9: 562-574.
6. Bakker, C. E. and Oostra, B. A. (2003) Understanding Fragile X syndrome: Insights from animal models. Cytogenet Genome Res 100: 111-123.
7. Bardoni, B., Davidovic, L., Bensaid, M., and Khandjian, E. W. (2006) The Fragile X syndrome: Exploring its molecular basis and seeking a treatment. Expert Rev Mol Med 8: 1-16.
8. Bear, M. F., Huber, K. M., and Warren, S. T. (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci 27: 370-377.
9. Belmonte, M. K. and Bourgeron, T. (2006) Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 9: 1221-1225.
10. Berry-Kravis, E., Hessl, D., Cofey, S., et al. (2009) A pilot open label, single dose trial of fenobam in adults with Fragile X syndrome. J MedGenet 46: 266-271.
11. Bhattacharya, A., Kaphzan, H., Alvarez-Dieppa, A. C., et al. (2012) Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in Fragile X syndrome mice. Neuron 76: 325-337.
12. Bilousova, T. V., Dansie, L., Ngo, M., et al. (2009) Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 46: 94-102.
13. Bontekoe, C. J., Bakker, C. E., Nieuwenhuizen, I. M., et al. (2001) Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum Mol Genet 10: 1693-1699.
14. Bontekoe, C. J., McIlwain, K. L., Nieuwenhuizen, I. M., et al. (2002) Knockout mouse model for Fxr2: A model for mental retardation. Hum Mol Genet 11: 487-498.
15. Branchi, I., Santucci, D., and Alleva, E. (2001) Ultrasonic vocalisation emitted by infant rodents: A tool for assessment of neurobehavioural development. Behav Brain Res 125: 49-56.
16. Bregman, J. D., Leckman, J. F., and Ort, S. I. (1988) Fragile X syndrome: Genetic predisposition to psychopathology. J Autism Dev Disord 18: 343-354.
17. Brennan, F. X., Albeck, D. S., and Paylor, R. (2006) Fmr1 knockout mice are impaired in a leverpress escape/avoidance task. Genes Brain Behav 5: 467-471.
18. Brock, M. and Hatton, D. (2010) Distinguishing features of autism in boys with Fragile X syndrome. J Intellect Disabil Res 54: 894-905.
19. Brouwer, J. R., Mientjes, E. J., Bakker, C. E., et al. (2007) Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res 313: 244-253.
20. Budimirovic, D. B. and Kaufmann, W. E. (2011) What can we learn about autism from studying Fragile X syndrome? Dev Neurosci 33: 379-394.
21. Buxbaum, J. D., Betancur, C., Bozdagi, O., et al. (2012) Optimizing the phenotyping of rodent ASD models: Enrichment analysis of mouse and human neurobiological phenotypes associated with high-risk autism genes identiies morphological, electrophysiological, neurological, and behavioral features. Mol Autism 3: 1.
22. Caudy, A. A., Myers, M., Hannon, G. J., and Hammond, S. M. (2002) Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 16: 2491-2496.
23. Chen, L. and Toth, M. (2001) Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103: 1043-1050.
24. Comery, T. A., Harris, J. B., Willems, P. J., et al. (1997) Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deicits. Proc Natl Acad Sci USA 94: 5401-5404.
25. Cook, D., Sanchez-Carbente Mdel, R., Lachance, C., et al. (2011) Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus. PLoS One 6: E26120.
26. Crawford, D. C., Acuna, J. M., and Sherman, S. L. (2001) FMR1 and the Fragile X syndrome: Human genome epidemiology review. Genet Med 3: 359-371.
27. Crusio, W. E. (2004) Flanking gene and genetic background problems in genetically manipulated mice. Biol Psychiatry 56: 381-385.
28. Cruz-Martin, A., Crespo, M., and Portera-Cailliau, C. (2010) Delayed stabilization of dendritic spines in fragile X mice. J Neurosci 30: 7793-7803.
29. Curia, G., Papouin, T., Seguela, P., and Avoli, M. (2009) Downregulation of tonic GABAergic inhibition in a mouse model of Fragile X syndrome. Cereb Cortex 19: 1515-1520.
30. D’Hooge, R., Nagels, G., Franck, F., et al. (1997) Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience 76: 367-376.
31. Dahlhaus, R. and El-Husseini, A. (2010) Altered neuroligin expression is involved in social deicits in a mouse model of the Fragile X syndrome. Behav Brain Res 208: 96-105.
32. de Diego-Otero, Y., Romero-Zerbo, Y., el Bekay, R., et al. (2009) Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: An experimental therapeutic approach for the Fmr1 deiciency. Neuropsychopharmacology 34: 1011-1026.
33. de Vrij, F. M., Levenga, J., van der Linde, H. C., et al. (2008) Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31: 127-132.
34. den Broeder, M. J., van der Linde, H., Brouwer, J. R., et al. (2009) Generation and characterization of FMR1 knockout zebraish. PLoS One 4: E7910.
35. Devys, D., Lutz, Y., Rouyer, N., Bellocq, J. P., and Mandel, J. L. (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4: 335-340.
36. Dobkin, C., Rabe, A., Dumas, R., et al. (2000) Fmr1 knockout mouse has a distinctive strain-speciic learning impairment. Neuroscience 100: 423-429.
37. Dolan, B. M., Duron, S. G., Campbell, D. A., et al. (2013) Rescue of Fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc Nat Acad Sci USA 110: 5671-5676.
38. Dutch-Belgian Fragile X Consortium (1994) Fmr1 knockout mice: A model to study fragile X mental retardation. Cell 78: 23-33.
39. Dyer-Friedman, J., Glaser, B., Hessl, D., et al. (2002) Genetic and environmental inluences on the cognitive outcomes of children with Fragile X syndrome. J Am Acad Child Adolesc Psychiatry 41: 237-244.
40. Eadie, B. D., Zhang, W. N., Boehme, F., et al. (2009) Fmr1 knockout mice show reduced anxiety and alterations in neurogenesis that are speciic to the ventral dentate gyrus. Neurobiol Dis 36: 361-373.
41. Eberhart, D. E., Malter, H. E., Feng, Y., and Warren, S. T. (1996) The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5: 1083-1091.
42. Edbauer, D., Neilson, J. R., Foster, K. A., et al. (2010) Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65: 373-384.
43. Endo, T., Maekawa, F., Voikar, V., et al. (2011) Automated test of behavioral lexibility in mice using a behavioral sequencing task in IntelliCage. Behav Brain Res 221: 172-181.
44. Errijgers, V., Fransen, E., D’Hooge, R., De Deyn, P. P., and Kooy, R. F. (2008) Efect of genetic background on acoustic startle response in fragile X knockout mice. Genet Res 90: 341-345.
45. Frankland, P. W., Wang, Y., Rosner, B., et al. (2004) Sensorimotor gating abnormalities in young males with Fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9: 417-425.
46. Fu, Y. H., Kuhl, D. P., Pizzuti, A., et al. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67: 1047-1058.
47. Galvez, R. and Greenough, W. T. (2005) Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am J Med Genet A 135A: 155-160.
48. Gantois, I., Bakker, C. E., Reyniers, E., et al. (2001) Restoring the phenotype of Fragile X syndrome: Insight from the mouse model. Curr Mol Med 1: 447-455.
49. Gantois, I., Pop, A. S., de Esch, C. E., et al. (2013) Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice. Behav Brain Res 239: 72-79.
50. Gonzalez, C. L., Kolb, B., andWhishaw, I. Q. (2000) A cautionary note regarding drug and brain lesion studies that use swimming pool tasks: Partial reinforcement impairs acquisition of place learning in a swimming pool but not on dry land. Behav Brain Res 112: 43-52.
51. Gould, E. L., Loesch, D. Z., Martin, M. J., et al. (2000) Melatonin proiles and sleep characteristics in boys with Fragile X syndrome: A preliminary study. Am J Med Genet 95: 307-315.
52. Greenough, W. T., Klintsova, A. Y., Irwin, S. A., et al. (2001) Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci USA 98: 7101-7106.
53. Hagerman, P. J. (2008) The fragile X prevalence paradox. J Med Genet 45: 498-499.
54. Hagerman, R. J. (2006) Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J Dev Behav Pediatr 27: 63-74.
55. Hagerman, R. J., Amiri, K., and Cronister, A. (1991) Fragile X checklist. Am J Med Genet 38: 283-287.
56. Hatton, D. D., Sideris, J., Skinner, M., et al. (2006) Autistic behavior in children with Fragile X syndrome: Prevalence, stability, and the impact of FMRP. Am J Med Genet A 140A: 1804-1813.
57. Hayashi, M. L., Rao, B. S., Seo, J. S., et al. (2007) Inhibition of p21-activated kinase rescues symptoms of Fragile X syndrome in mice. Proc Natl Acad Sci USA 104: 11489-11494.
58. He, C. X. and Portera-Cailliau, C. (2013) The trouble with spines in Fragile X syndrome: Density, maturity and plasticity. Neuroscience 251: 120-128.
59. Heitzer, A. M., Roth, A. K., Nawrocki, L., et al. (2013) Brief report: Altered social behavior in isolation-reared Fmr1 knockout mice. J AutismDevDisord 43:1452-1458.
60. Hessl, D., Dyer-Friedman, J., Glaser, B., et al. (2001) The inluence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with Fragile X syndrome. Pediatrics 108: E88.
61. Heulens, I., D’Hulst, C., Van Dam, D., De Deyn, P. P., and Kooy, R. F. (2012) Pharmacological treatment of Fragile X syndrome with GABAergic drugs in a knockout mouse model. Behav Brain Res 229: 244-249.
62. Heulens, I. and Kooy, F. (2011) Fragile X syndrome: From gene discovery to therapy. Front Biosci 16: 1211-1232.
63. Hoogeveen, A. T., Willemsen, R., and Oostra, B. A. (2002) Fragile X syndrome, the Fragile X related proteins, and animal models. Microsc Res Tech 57: 148-155.
64. Huber, K. M., Gallagher, S. M., Warren, S. T., and Bear, M. F. (2002) Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99: 7746-7750.
65. Inoue, S., Shimoda, M., Nishinokubi, I., et al. (2002) A role for the Drosophila fragile X-related gene in circadian output. Curr Biol 12: 1331-1335.
66. Jin, P. and Warren, S. T. (2003) New insights into Fragile X syndrome: From molecules to neurobehaviors. Trends Biochem Sci 28: 152-158.
67. Jin, P., Zarnescu, D. C., Ceman, S., et al. (2004) Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 7: 113-117.
68. Jin, P., Zarnescu, D. C., Zhang, F., et al. (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39: 739-747.
69. Jung, K. M., Sepers, M., Henstridge, C. M., et al. (2012) Uncoupling of the endocannabinoid signalling complex in a mouse model of Fragile X syndrome. Nat Commun 3: 1080.
70. Kenneson, A., Zhang, F., Hagedorn, C. H., andWarren, S. T. (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10: 1449-1454.
71. Kerby, D. S. and Dawson, B. L. (1994) Autistic features, personality, and adaptive behavior in males with the Fragile X syndrome and no autism. Am J Ment Retard 98: 455-462.
72. Koekkoek, S. K., Yamaguchi, K., Milojkovic, B. A., et al. (2005) Deletion of FMR1 in Purkinje cells enhances parallel iber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron 47: 339-352.
73. Kooy, R. F. (2003) Of mice and the Fragile X syndrome. Trends Genet 19: 148-154.
74. Kooy, R. F., D’Hooge, R., Reyniers, E., et al. (1996) Transgenic mouse model for the Fragile X syndrome. Am J Med Genet 64: 241-245.
75. Laggerbauer, B., Ostareck, D., Keidel, E. M., Ostareck-Lederer, A., and Fischer, U. (2001) Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 10: 329-338.
76. Lee, A., Li, W., Xu, K., et al. (2003) Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1. Development 130: 5543-5552.
77. Liu, Z. H., Chuang, D. M., and Smith, C. B. (2011) Lithium ameliorates phenotypic deicits in a mouse model of Fragile X syndrome. Int J Neuropsychopharmacol 14: 618-630.
78. Liu, Z. H., Huang, T., and Smith, C. B. (2012) Lithium reverses increased rates of cerebral protein synthesis in a mouse model of Fragile X syndrome. Neurobiol Dis 45: 1145-1152.
79. Loesch, D. Z., Bui, Q. M., Dissanayake, C., et al. (2007) Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neurosci Biobehav Rev 31: 315-326.
80. Loesch, D. Z., Bui, Q. M., Grigsby, J., et al. (2003) Efect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X. Neuropsychology 17: 646-657.
81. Loesch, D. Z. and Hay, D. A. (1988) Clinical features and reproductive patterns in fragile X female heterozygotes. J Med Genet 25: 407-414.
82. Louhivuori, V., Vicario, A., Uutela, M., et al. (2011) BDNF and TrkB in neuronal diferentiation of Fmr1-knockout mouse. Neurobiol Dis 41: 469-480.
83. Markham, J. A., Beckel-Mitchener, A. C., Estrada, C. M., and Greenough, W. T. (2006) Corticosterone response to acute stress in a mouse model of Fragile X syndrome. Psychoneuroendocrinology 31: 781-785.
84. Mazzocco, M. M., Kates, W. R., Baumgardner, T. L., Freund, L. S., and Reiss, A. L. (1997) Autistic behaviors among girls with Fragile X syndrome. J AutismDevDisord 27: 415-435.
85. Mazzocco, M. M., Pulsifer, M., Fiumara, A., et al. (1998) Brief report: Autistic behaviors among children with fragile X or Rett syndrome: Implications for the classiication of pervasive developmental disorder. J AutismDevDisord 28: 321-328.
86. McAlonan, G. M., Daly, E., Kumari, V., et al. (2002) Brain anatomy and sensorimotor gating in Asperger’s syndrome. Brain 125: 1594-1606.
87. McBride, S. M., Choi, C. H., Wang, Y., et al. (2005) Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of Fragile X syndrome. Neuron 45: 753-764.
88. McNaughton, C. H., Moon, J., Strawderman, M. S., et al. (2008) Evidence for social anxiety and impaired social cognition in a mouse model of Fragile X syndrome. Behav Neurosci 122: 293-300.
89. Meredith, R. M., Holmgren, C. D., Weidum, M., Burnashev, N., and Mansvelder, H. D. (2007) Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1. Neuron 54: 627-638.
90. Michel, C. I., Krat, R., and Restifo, L. L. (2004) Defective neuronal development in the mushroom bodies of Drosophila fragile X mental retardation 1 mutants. J Neurosci 24: 5798-5809.
91. Mientjes, E. J., Nieuwenhuizen, I., Kirkpatrick, L., et al. (2006) The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol Dis 21: 549-555.
92. Mientjes, E. J., Willemsen, R., Kirkpatrick, L. L., et al. (2004) Fxr1 knockout mice show a striated muscle phenotype: Implications for Fxr1p function in vivo. Hum Mol Genet 13: 1291-1302.
93. Mines, M. A. and Jope, R. S. (2011) Glycogen synthase kinase-3: A promising therapeutic target for fragile x syndrome. Front Mol Neurosci 4: 35.
94. Mines, M. A., Yuskaitis, C. J., King, M. K., Beurel, E., and Jope, R. S. (2010) GSK3 inluences social preference and anxiety-related behaviors during social interaction in a mouse model of Fragile X syndrome and autism. PLoS One 5: E9706.
95. Mineur, Y. S., Huynh, L. X., and Crusio, W. E. (2006) Social behavior deicits in the Fmr1 mutant mouse. Behav Brain Res 168: 172-175.
96. Mineur, Y. S., Sluyter, F., deWit, S., Oostra, B. A., and Crusio, W. E. (2002) Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 12: 39-46.
97. Morales, J., Hiesinger, P. R., Schroeder, A. J., et al. (2002) Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 34: 961-972.
98. Moskowitz, L. J., Carr, E. G., and Durand, V. M. (2011) Behavioral intervention for problem behavior in children with Fragile X syndrome. Am J Intellect Dev Disabil 116: 457-478.
99. Moy, S. S., Nadler, J. J., Magnuson, T. R., and Crawley, J. N. (2006) Mouse models of autism spectrum disorders: The challenge for behavioral genetics. Am J Med Genet C Semin Med Genet 142C: 40-51.
100. Musumeci, S. A., Bosco, P., Calabrese, G., et al. (2000) Audiogenic seizures susceptibility in transgenic mice with Fragile X syndrome. Epilepsia 41: 19-23.
101. Musumeci, S. A., Hagerman, R. J., Ferri, R., et al. (1999) Epilepsy and EEG indings in males with Fragile X syndrome. Epilepsia 40: 1092-1099.
102. Nakamoto, M., Nalavadi, V., Epstein, M. P., et al. (2007) Fragile X mental retardation protein deiciency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc Natl Acad Sci USA 104: 15537-15542.
103. Nalavadi, V. C., Muddashetty, R. S., Gross, C., and Bassell, G. J. (2012) Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: A role in immediate early mGluR-stimulated translation. J Neurosci 32: 2582-2587.
104. Napoli, I., Mercaldo, V., Boyl, P. P., et al. (2008) The Fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134: 1042-1054.
105. Nielsen, D. M., Derber, W. J., McClellan, D. A., and Crnic, L. S. (2002) Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of Fragile X syndrome. Brain Res 927: 8-17.
106. Nimchinsky, E. A., Oberlander, A. M., and Svoboda, K. (2001) Abnormal development of dendritic spines in FMR1 knock-out mice. J Neurosci 21: 5139-5146.
107. Oddi, D., Crusio, W. E., D’Amato, F. R., and Pietropaolo, S. (2013) Monogenic mouse models of social dysfunction: Implications for autism. Behav Brain Res 251: 75-84.
108. Olmos-Serrano, J. L., Corbin, J. G., and Burns, M. P. (2011) The GABA(A) receptor agonist THIP ameliorates speciic behavioral deicits in the mouse model of Fragile X syndrome. Dev Neurosci 33: 395-403.
109. Oostra, B. A. (1996) Fragile X syndrome in humans and mice. Acta Genet Med Gemellol 45: 93-108.
110. Pacey, L. K., Heximer, S. P., and Hampson, D. R. (2009) Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures. Mol Pharmacol 76: 18-24.
111. Paluszkiewicz, S. M., Martin, B. S., and Huntsman, M. M. (2011) Fragile X syndrome: The GABAergic system and circuit dysfunction. Dev Neurosci 33: 349-364.
112. Paradee, W., Melikian, H. E., Rasmussen, D. L., et al. (1999) Fragile X mouse: Strain efects of knockout phenotype and evidence suggesting deicient amygdala function. Neuroscience 94: 185-192.
113. Paribello, C., Tao, L., Folino, A., et al. (2010) Open-label add-on treatment trial of minocycline in Fragile X syndrome. BMC Neurol 10: 91.
114. Peier, A. M., McIlwain, K. L., Kenneson, A., et al. (2000) (Over)correction of FMR1 deiciency with YAC transgenics: Behavioral and physical features. Hum Mol Genet 9: 1145-1159.
115. Perry, W., Minassian, A., Lopez, B., Maron, L., and Lincoln, A. (2007) Sensorimotor gating deicits in adults with autism. Biol Psychiatry 61: 482-486.
116. Pieretti, M., Zhang, F. P., Fu, Y. H., et al. (1991) Absence of expression of the FMR-1 gene in Fragile X syndrome. Cell 66: 817-822.
117. Pietropaolo, S., Guilleminot, A., Martin, B., D’Amato, F. R., and Crusio, W. E. (2011) Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice. PLoS One 6: E17073.
118. Pilpel, Y., Kolleker, A., Berberich, S., et al. (2009) Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 ield of Fmr1 knockout mice. J Physiol 587: 787-804.
119. Pop, A. S., Levenga, J., de Esch, C. E., et al. (2012) Rescue of dendritic spine phenotype in Fmr1 KOmice with the mGluR5 antagonist AFQ056/Mavoglurant. Psychopharmacology 231: 1227-1235.
120. Qin, M., Kang, J., and Smith, C. B. (2002) Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99: 15758-15763.
121. Qin, M., Kang, J., and Smith, C. B. (2005) A null mutation for Fmr1 in female mice: Efects on regional cerebral metabolic rate for glucose and relationship to behavior. Neuroscience 135: 999-1009.
122. Qin, M., Xia, Z., Huang, T., and Smith, C. B. (2011) Efects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice. Neuroscience 194: 282-290.
123. Qiu, C., Sora, I., Ren, K., Uhl, G., and Dubner, R. (2000) Enhanced delta-opioid receptor-mediated antinociception in mu-opioid receptor-deicient mice. Eur J Pharmacol 387: 163-169.
124. Qiu, L. F., Lu, T. J., Hu, X. L., et al. (2009) Limbic epileptogenesis in a mouse model of Fragile X syndrome. Cereb Cortex 19: 1504-1514.
125. Radde, R., Duma, C., Goedert, M., and Jucker, M. (2008) The value of incomplete mouse models of Alzheimer’s disease. Eur J Nucl MedMol Imaging (35 Suppl 1): S70-S74.
126. Reiss, A. L. and Freund, L. (1992) Behavioral phenotype of Fragile X syndrome: DSM-III-R autistic behavior in male children. Am J Med Genet 43: 35-46.
127. Restivo, L., Ferrari, F., Passino, E., et al. (2005) Enriched environment promotes behavioral and morphological recovery in a mouse model for the Fragile X syndrome. Proc Natl Acad Sci USA 102: 11557-11562.
128. Ricceri, L., Moles, A., and Crawley, J. (2007) Behavioral phenotyping of mouse models of neurodevelopmental disorders: Relevant social behavior patterns across the life span. Behav Brain Res 176: 40-52.
129. Rogers, S. J., Wehner, D. E., and Hagerman, R. (2001) The behavioral phenotype in fragile X: Symptoms of autism in very young children with Fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr 22: 409-417.
130. Rotschafer, S. E., Trujillo, M. S., Dansie, L. E., Ethell, I. M., and Razak, K. A. (2012) Minocycline treatment reverses ultrasonic vocalization production deicit in a mouse model of Fragile X Syndrome. Brain Res 1439: 7-14.
131. Roy, S., Watkins, N., and Heck, D. (2012) Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile x syndrome reveals limited, call type speciic deicits. PLoS One 7: E44816.
132. Sakai, K. and Miyazaki, J. (1997) A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Comm 237: 318-324.
133. Scattoni, M. L., Crawley, J., and Ricceri, L. (2009) Ultrasonic vocalizations: A tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev 33: 508-515.
134. Sekine, T., Yamaguchi, T., Hamano, K., et al. (2008) Circadian phenotypes of Drosophila fragile x mutants in alternative genetic backgrounds. Zoolog Sci 25: 561-571.
135. Shan, G., Xu, S., and Jin, P. (2008) FXTAS: A bad RNAand a hope for a cure. Expert Opin Biolher 8: 249-253.
136. Siomi, H., Siomi, M. C., Nussbaum, R. L., and Dreyfuss, G. (1993) The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74: 291-298.
137. Siomi, M. C., Zhang, Y., Siomi, H., and Dreyfuss, G. (1996) Speciic sequences in the Fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol 16: 3825-3832.
138. Slegtenhorst-Eegdeman, K. E., de Rooij, D. G., Verhoef-Post, M., et al. (1998) Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development. Endocrinology 139: 156-162.
139. Spear, L. P. (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
140. Spencer, C. M., Alekseyenko, O., Hamilton, S. M., et al. (2011) Modifying behavioral phenotypes in Fmr1KO mice: Genetic background diferences reveal autistic-like responses. Autism Res 4: 40-56.
141. Spencer, C. M., Alekseyenko, O., Serysheva, E., Yuva-Paylor, L. A., and Paylor, R. (2005) Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of Fragile X syndrome. Genes Brain Behav 4: 420-430.
142. Spencer, C. M., Graham, D. F., Yuva-Paylor, L. A., Nelson, D. L., and Paylor, R. (2008) Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene. Behav Neurosci 122: 710-715.
143. Spencer, C. M., Serysheva, E., Yuva-Paylor, L. A., et al. (2006) Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. Hum Mol Genet 15: 1984-1994.
144. Symons, F. J., Clark, R. D., Hatton, D. D., Skinner, M., and Bailey, D. B., Jr. (2003) Self-injurious behavior in young boys with Fragile X syndrome. Am J Med Genet A 118A: 115-121.
145. Tamanini, F., Willemsen, R., van Unen, L., et al. (1997) Diferential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum Mol Genet 6: 1315-1322.
146. Terranova, M. L., Laviola, G., and Alleva, E. (1993) Ontogeny of amicable social behavior in the mouse: Gender diferences and ongoing isolation outcomes. Dev Psychobiol 26: 467-481.
147. Terranova, M. L., Laviola, G., de Acetis, L., and Alleva, E. (1998) A description of the ontogeny of mouse agonistic behavior. J Comp Psychol 112: 3-12.
148. homas, A. M., Bui, N., Graham, D., et al. (2011) Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for Fragile X syndrome. Behav Brain Res 223: 310-321.
149. Toniolo, D. (2006) X-linked premature ovarian failure: A complex disease. Curr Opin Genet Dev 16: 293-300.
150. Tsiouris, J. A. and Brown, W. T. (2004) Neuropsychiatric symptoms of Fragile X syndrome: Pathophysiology and pharmacotherapy. CNS Drugs 18: 687-703.
151. Tucker, B., Richards, R. I., and Lardelli, M. (2006) Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and Fragile X syndrome. Hum Mol Genet 15: 3446-3458.
152. Utari, A., Chonchaiya, W., Rivera, S. M., et al. (2010) Side efects of minocycline treatment in patients with Fragile X syndrome and exploration of outcome measures. Am J Intellect Dev Disabil 115: 433-443.
153. Uutela, M., Lindholm, J., Louhivuori, V., et al. (2012) Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deicits but improves hyperactivity and sensorimotor deicits. Genes Brain Behav 11: 513-523.
154. Van Dam, D., D’Hooge, R., Hauben, E., et al. (2000) Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice. Behav Brain Res 117: 127-136.
155. Van Dam, D., Errijgers, V., Kooy, R. F., et al. (2005) Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behav Brain Res 162: 233-239.
156. Veeraragavan, S., Graham, D., Bui, N., et al. (2011) Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of Fragile X syndrome (FXS). Behav Brain Res 228: 1-8.
157. Ventura, R., Pascucci, T., Catania, M. V., Musumeci, S. A., and Puglisi-Allegra, S. (2004) Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: Involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol 15: 433-442.
158. Verkerk, A. J., Pieretti, M., Sutclife, J. S., et al. (1991) Identiication of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in Fragile X syndrome. Cell 65: 905-914.
159. Wan, L., Dockendorf, T. C., Jongens, T. A., and Dreyfuss, G. (2000) Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein. Mol Cell Biol 20: 8536-8547.
160. Wang, L. W., Berry-Kravis, E., and Hagerman, R. J. (2010) Fragile X: Leading the way for targeted treatments in autism. Neurotherapeutics 7: 264-274.
161. Westmark, C. J., Westmark, P. R., O’Riordan, K. J., et al. (2011) Reversal of fragile X phenotypes by manipulation of A beta PP/A beta levels in Fmr1KO mice. PLoS One 6: E26549.
162. Whishaw, I. Q. and Tomie, J. (1996) Of mice and mazes: Similarities between mice and rats on dry land but not water mazes. Physiol Behav 60: 1191-1197.
163. Wolfer, D. P., Crusio, W. E., and Lipp, H. P. (2002) Knockout mice: Simple solutions to the problems of genetic background and lanking genes. Trends Neurosci 25: 336-340.
164. Xu, K., Bogert, B. A., Li, W., et al. (2004) The fragile X-related gene afects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein pickpocket1. Curr Biol 14: 1025-1034.
165. Yan, Q. J., Asafo-Adjei, P. K., Arnold, H. M., Brown, R. E., and Bauchwitz, R. P. (2004) A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav 3: 337-359.
166. Yan, Q. J., Rammal, M., Tranfaglia, M., and Bauchwitz, R. P. (2005) Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49: 1053-1066.
167. Yang, Q., Feng, B., Zhang, K., et al. (2012) Excessive astrocyte-derived neurotrophin-3 contributes to the abnormal neuronal dendritic development in a mouse model of Fragile X syndrome. PLoS Genet 8: E1003172.
168. Yuhas, J., Cordeiro, L., Tassone, F., et al. (2011) Brief report: Sensorimotor gating in idiopathic autism and autism associated with Fragile X syndrome. J AutismDevDisord 41: 248-253.
169. Yuskaitis, C. J., Beurel, E., and Jope, R. S. (2010a) Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochim Biophys Acta 1802: 1006-1012.
170. Yuskaitis, C. J., Mines, M. A., King, M. K., et al. (2010b) Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome. Biochem Pharmacol 79: 632-646.
171. Zhang, J., Fang, Z., Jud, C., et al. (2008) Fragile X-related proteins regulate mammalian circadian behavioral rhythms. Am J Hum Genet 83: 43-52.
172. Zhang, J., Hou, L., Klann, E., andNelson, D. L. (2009) Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. J Neurophysiol 101: 2572-2580.
173. Zhao, M. G., Toyoda, H., Ko, S. W., et al. (2005) Deicits in trace fear memory and long-termpotentiation in a mouse model for Fragile X syndrome. J Neurosci 25: 7385-7392.
174. Zupan, B. and Toth, M. (2008)Wild-type male ofspring of fmr-1+/-mothers exhibit characteristics of the fragile X phenotype. Neuropsychopharmacology 33: 2667-2675.